News

PharmaCielo Announces the Appointment of Cannabis Industry Veterans Bob DeGabrielle and Will Nicholas to the Company’s Board

September 1, 2021 DeGabrielle was an early entrepreneur and executive in the U.S. cannabis industry; he founded and owns Los Sueños Farms LLC, the largest outdoor grow in North America, which he recently agreed to sell to Curaleaf, Inc. Nicholas is an experienced finance professional

PharmaCielo Announces the New Appointment of Bill Petron as CEO

August 20, 2021 Bill Petron, the Company's Chairman and a global operations and cannabis veteran, has been appointed Chief Executive Officer of PharmaCielo. Bill Petron is a highly respected entrepreneur with a diverse background in manufacturing, logistics and medical cannabis. He founded companies as MSI

Canadian-Colombian Cannabis Co. PharmaCielo Expands In Brazil With New Pharma Customer

Canadian-Colombian medical cannabis extracts producer PharmaCielo Ltd (TSXV:PCLO) (OTCQX:PCLOF) added another Brazilian-based customer to its roster. The company announced this week that it signed a sales agreement and already completed an initial commercial sale of CBD Isolate to an undisclosed pharmaceutical company To continue reading,

Latest Interview to our CEO by Mugglehead Magazine

July 28, 2021 Find the latest interview that our CEO, Henning von Koss had with a Canadian cannabis magazine, Mugglehead, where he provided insights and context about the new regulations introduced by the Colombian President as well as how PharmaCielo is going to take advantage

Interview with Henning Von Koss, CEO, and Canada’s Business of Cannabis

July 1, 2021 Our CEO, Henning von Koss, recently interviewed with Canada’s Business of Cannabis where he discussed the company’s increased focus on becoming a product developing partner to clients through an early integration into their supply chains with higher-value and innovative extracts and APIs.

MMJ Daily interviewed our CEO, Henning Von Koss

June 17, 2021 Our CEO, Henning von Koss, talked recently with MMJ Daily - an international media platform for legal and professional growers, researchers and suppliers in the global medical cannabis industry. During the interview, Henning outlined PharmaCielo’s long-term strategic approach, setting the standard for

Interview with our CEO, Henning Von Koss, by Rena Sherbill the Cannabis editor of Seeking Alpha

June 11, 2021 Our CEO, Henning von Koss was recently interviewed by Rena Sherbill the Cannabis editor of Seeking Alpha, a leading investment intelligence and news media outlet. In this interview, Mr. Von Koss talks about PharmaCielo’s unique business strategy and market position as a

PharmaCielo Delivers First Commercial Shipment of THC-Free Broad-Spectrum Distillate

Shipped to existing Customer with operations in the U.K. and the E.U. THC-free broad-spectrum distillate from a single cultivar is a superior core formulation for nutraceutical and cosmetic formulations. PharmaCielo is among the few global producers that deliver broad-spectrum formulations produced from specially selected, developed

PharmaCielo Provides Update on GMP Compliance Process

Colombian and Mexican GMP certifications expected during Q1'21 and Q2'21, respectively The Company confirms that its recently completed Processing and Extraction Center at its Rionegro facility, Colombia's largest scale processing centre, will be producing extracts in compliance with EU-GMP guidelines by the end of February. TORONTO and RIONEGRO, Colombia,

PharmaCielo Enters Strategic Alliance to Provide Pre-Tested, Insured Product to Customers in US Market

Alliance with AssuredTrans, Inc. will enable PharmaCielo to provide up-front independent laboratory analysis and insurance of its recently expanded product portfolio to potential customers in the U.S., beginning in 2021 Former congressman notes alliance enables U.S. customers to have confidence in the purity and quality